Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Sep;86(3):769–776. doi: 10.1172/JCI114773

Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.

N Harata 1, T Sasaki 1, H Osaki 1, T Saito 1, S Shibata 1, T Muryoi 1, O Takai 1, K Yoshinaga 1
PMCID: PMC296791  PMID: 2144300

Abstract

-81 and NE-1 idiotypes (Id) of human nephritogenic anti-DNA antibodies are interspecies Id expressed also in NZB/W F1 mice. We tried to manipulate the synthesis of spontaneously occurring anti-DNA antibody using monoclonal anti-Id antibodies (D1E2 and 1F5) conjugated with a cytotoxic agent, neocarzinostatin (NCS). In vivo administration of anti-Id antibodies conjugated with NCS brought about an improvement in the survival rate of female NZB/W F1 mice. It also caused a retardation of development of lupus nephritis and decreased the numbers of anti-DNA-producing cells. The suppression of anti-DNA antibody synthesis was specific and Id-mediated. The results indicate that the use of a limited number of anti-Id antibodies in combination with a cytotoxic agent may be applicable therapeutically to autoimmune diseases.

Full text

PDF
769

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Wall H., Lindsley H. B., Halsey J. F., Suzuki T. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest. 1981 May;67(5):1297–1304. doi: 10.1172/JCI110158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agius M. A., Richman D. P. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody. J Immunol. 1986 Oct 1;137(7):2195–2198. [PubMed] [Google Scholar]
  3. Ando D. G., Ebling F. M., Hahn B. H. Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay. A clinical study of (New Zealand black x New Zealand white)F1 mice. Arthritis Rheum. 1986 Sep;29(9):1139–1146. doi: 10.1002/art.1780290912. [DOI] [PubMed] [Google Scholar]
  4. Austin H. A., 3rd, Muenz L. R., Joyce K. M., Antonovych T. T., Balow J. E. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984 Apr;25(4):689–695. doi: 10.1038/ki.1984.75. [DOI] [PubMed] [Google Scholar]
  5. Bona C. A., Victor-Kobrin C., Manheimer A. J., Bellon B., Rubinstein L. J. Regulatory arms of the immune network. Immunol Rev. 1984 Jun;79:25–44. doi: 10.1111/j.1600-065x.1984.tb00485.x. [DOI] [PubMed] [Google Scholar]
  6. Bona C., Paul W. E. Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med. 1979 Mar 1;149(3):592–600. doi: 10.1084/jem.149.3.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DeShambo R. M., Krolick K. A. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin. J Immunol. 1986 Nov 15;137(10):3135–3139. [PubMed] [Google Scholar]
  8. Dwyer D. S., Bradley R. J., Urquhart C. K., Kearney J. F. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature. 1983 Feb 17;301(5901):611–614. doi: 10.1038/301611a0. [DOI] [PubMed] [Google Scholar]
  9. Eichmann K., Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol. 1975 Oct;5(10):661–666. doi: 10.1002/eji.1830051002. [DOI] [PubMed] [Google Scholar]
  10. Epstein A., Greenberg M., Diamond B., Grayzel A. I. Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotypic antibody. J Clin Invest. 1987 Mar;79(3):997–1000. doi: 10.1172/JCI112912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hahn B. H., Ebling F. M. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol. 1984 Jan;132(1):187–190. [PubMed] [Google Scholar]
  12. Jung G., Köhnlein W., Lüders G. Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate. Biochem Biophys Res Commun. 1981 Jul 30;101(2):599–606. doi: 10.1016/0006-291x(81)91301-2. [DOI] [PubMed] [Google Scholar]
  13. Kavanagh F. Antibiotic assays principles and precautions. Methods Enzymol. 1975;43:55–69. doi: 10.1016/0076-6879(75)43080-4. [DOI] [PubMed] [Google Scholar]
  14. Knight J. G., Adams D. D., Purves H. D. The genetic contribution of the NZB mouse to the renal disease of the NZB x NZW hybrid. Clin Exp Immunol. 1977 May;28(2):352–358. [PMC free article] [PubMed] [Google Scholar]
  15. Koopman W. J., Schrohenloher R. E., Barton J. C., Greenleaf E. C. Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements. J Clin Invest. 1983 Oct;72(4):1410–1419. doi: 10.1172/JCI111097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rosse W. F. Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment. J Clin Invest. 1971 Apr;50(4):734–743. doi: 10.1172/JCI106544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sasaki T., Endo F., Mikami M., Sekiguchi Y., Tada K., Ono Y., Ishida N., Yoshinaga K. Establishment of human monoclonal anti-DNA antibody producing cell lines. J Immunol Methods. 1984 Aug 3;72(1):157–165. doi: 10.1016/0022-1759(84)90443-5. [DOI] [PubMed] [Google Scholar]
  18. Sasaki T., Koide Y., Yoshigaga K. Immune suppression of anti-DNA antibody production using anti-idiotypic antibody-neocarzinostatin conjugates. Methods Enzymol. 1989;178:422–432. doi: 10.1016/0076-6879(89)78031-9. [DOI] [PubMed] [Google Scholar]
  19. Sasaki T., Muryoi T., Sekiguchi Y., Tamate E., Yoshinaga K., Kitagawa Y. Monoclonal human anti-DNA antibodies from EB virus-transformed lymphocytes of systemic lupus erythematosus (SLE) patients. J Clin Immunol. 1985 Jul;5(4):246–253. doi: 10.1007/BF00929459. [DOI] [PubMed] [Google Scholar]
  20. Sasaki T., Muryoi T., Takai O., Tamate E., Ono Y., Koide Y., Ishida N., Yoshinaga K. Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin. J Clin Invest. 1986 Apr;77(4):1382–1386. doi: 10.1172/JCI112444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sasaki T., Tamate E., Muryoi T., Takai O., Yoshinaga K. In vitro manipulation of human anti-DNA antibody production by anti-idiotypic antibodies conjugated with neocarzinostatin. J Immunol. 1989 Feb 15;142(4):1159–1165. [PubMed] [Google Scholar]
  22. Sim G. K., Augustin A. A. Internal images of major histocompatibility complex antigens on T-cell receptors and their role in the generation of the T-helper cell repertoire. Ann N Y Acad Sci. 1983;418:272–281. doi: 10.1111/j.1749-6632.1983.tb18075.x. [DOI] [PubMed] [Google Scholar]
  23. Takemori T., Rajewsky K. Specificity, duration and mechanism of idiotype suppression induced by neonatal injection of monoclonal anti-idiotope antibodies into mice. Eur J Immunol. 1984 Jul;14(7):656–667. doi: 10.1002/eji.1830140714. [DOI] [PubMed] [Google Scholar]
  24. Takeuchi T., Hosono O., Koide J., Homma M., Abe T. Suppression of rheumatoid factor synthesis by antiidiotypic antibody in rheumatoid arthritis patients with cross-reactive idiotypes. Arthritis Rheum. 1985 Aug;28(8):873–881. doi: 10.1002/art.1780280806. [DOI] [PubMed] [Google Scholar]
  25. Tamate E., Sasaki T., Muryoi T., Takai O., Otani K., Tada K., Yoshinaga K. Expression of idiotype on the surface of human B cells producing anti-DNA antibody. J Immunol. 1986 Feb 15;136(4):1241–1246. [PubMed] [Google Scholar]
  26. Teitelbaum D., Rauch J., Stollar B. D., Schwartz R. S. In vivo effects of antibodies against a high frequency idiotype of anti-DNA antibodies in MRL mice. J Immunol. 1984 Mar;132(3):1282–1285. [PubMed] [Google Scholar]
  27. Yamamoto H., Katz D. H. Biological effects of anti-idiotypic antibodies on lymphocyte function. I. Analysis of the effects on B lymphocytes of combining site and framework-directed anti-T-15 idiotypic antibodies. Cell Immunol. 1980 Mar 15;50(2):369–378. doi: 10.1016/0008-8749(80)90291-9. [DOI] [PubMed] [Google Scholar]
  28. Yoshiki T., Mellors R. C., Strand M., August J. T. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med. 1974 Oct 1;140(4):1011–1027. doi: 10.1084/jem.140.4.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zanetti M., Rogers J., Katz D. H. Induction of autoantibodies to thyroglobulin by anti-idiotypic antibodies. J Immunol. 1984 Jul;133(1):240–243. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES